Gail Cawkwell
SVP, Med Affairs, Safety & PV, Intercept Pharmaceuticals.
Companies
- Aclaris Therapeutics, Inc.Chief Medical Officer Jul 5, 2022 to Jul 5, 20231
- Intercept PharmaceuticalsSVP, Med Affairs, Safety & PV Dec 14, 2018 to Feb 15, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aclaris Therapeutics, Inc. ACRS9,593 shares3$31.5K at $3.28Jul 1, 2023
Intercept Pharmaceuticals ICPT35,740 shares4Feb 12, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2023Shares withheld for tax 5,407 shares at $10.37 of Aclaris Therapeutics, Inc.3
- Jul 1, 2023Exercised options 15,000 shares of Aclaris Therapeutics, Inc.3
- Feb 12, 2022Shares withheld for tax 320 shares at $15.80 of Intercept Pharmaceuticals4
- Jan 27, 2022Granted 6,600 shares of Intercept Pharmaceuticals5
- Dec 31, 2021Shares withheld for tax 2,455 shares at $16.29 of Intercept Pharmaceuticals6
- Nov 12, 2021Shares withheld for tax 319 shares at $19.04 of Intercept Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jan 31, 2022
- 6SEC EDGARForm 4 filed Jan 4, 2022
- 7SEC EDGARForm 4 filed Nov 16, 2021